Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019Jonathan Kocarnik, Etsay Woldu Anbesu, Rixing Xu et al.|JAMA Oncology|2021Cited by 2k
Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021Masayuki Teramoto, Shahzaib Ahmad, Hazim Ababneh et al.|The Lancet|2024Cited by 931
Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000–2021: a systematic analysis from the Global Burden of Disease Study 2021Azalea Thomson, Deepa Dongarwar, Theresa A. McHugh et al.|The Lancet Haematology|2023Cited by 674
Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021William M. Gardner, Rajaa Al‐Raddadi, Christian Razo et al.|The Lancet Haematology|2023Cited by 541
The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysisTomislav Meštrović, Alexander G. Mathioudakis, Mohsen Naghavi et al.|The Lancet Public Health|2022Cited by 350